Cardiovascular and metabolic outcomes associated with insulin use in type 2 diabetes : evidence from insulin users in the UK primary care
In clinical use, insulin improves glycaemic control at the cost, typically, of weight gain and more hypoglycaemia – both being risk factors for cardiovascular (CV) disease mortality. The issue of the effect of exogenous insulin on CV disease meanwhile has been debated for a long time. Data on the CV...
| Main Author: | |
|---|---|
| Published: |
University of Nottingham
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.740683 |